Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Suter

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|January 1, 1993
[The Neuchâtel Society of Dental Medicine. Interview by Kurt Venner]E Blaser, G Sterchi, R Vogel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors?E B Bröcker, L Suter, B M Czarnetzki, et al.
Hormone Research|January 11, 2001
Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolismA Biason-Lauber, S L Suter, C H Shackleton, et al.
Electrophoresis|June 27, 2001
Two-dimensional database of mouse liver proteins. An updateM Fountoulakis, J F Juranville, P Berndt, et al.
Archives of Dermatological Research|January 1, 1995
Mast cells in melanocytic tumoursD Schadendorf, C Kohlmus, C Gawlik, et al.
The Journal of Investigative Dermatology|September 1, 1980
Human malignant melanoma: assay of tumor associated antigens by use of rabbit antiseraL Suter, J Brüggen, F Vakilzadeh, et al.
Archives of Dermatological Research|May 19, 2001
The prognostic value of the expression of collagenase IV, cathepsin D and metallothionein in squamous cell carcinomas of the skin determined by immunohistochemistryT Goldmann, A Moorkamp, K H Wiedorn, et al.
Behring Institute Mitteilungen|May 1, 1984
The expression of tumor-associated antigens in primary and metastatic human malignant melanomaJ Brüggen, E B Bröcker, L Suter, et al.
Journal of the National Cancer Institute|March 1, 1995
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vesselsD Schadendorf, J Heidel, C Gawlik, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotypeE B Bröcker, G Zwadlo, L Suter, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|January 1, 1993
[The Neuchâtel Society of Dental Medicine. Interview by Kurt Venner]E Blaser, G Sterchi, R Vogel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors?E B Bröcker, L Suter, B M Czarnetzki, et al.
Hormone Research|January 11, 2001
Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolismA Biason-Lauber, S L Suter, C H Shackleton, et al.
Electrophoresis|June 27, 2001
Two-dimensional database of mouse liver proteins. An updateM Fountoulakis, J F Juranville, P Berndt, et al.
Archives of Dermatological Research|January 1, 1995
Mast cells in melanocytic tumoursD Schadendorf, C Kohlmus, C Gawlik, et al.
The Journal of Investigative Dermatology|September 1, 1980
Human malignant melanoma: assay of tumor associated antigens by use of rabbit antiseraL Suter, J Brüggen, F Vakilzadeh, et al.
Archives of Dermatological Research|May 19, 2001
The prognostic value of the expression of collagenase IV, cathepsin D and metallothionein in squamous cell carcinomas of the skin determined by immunohistochemistryT Goldmann, A Moorkamp, K H Wiedorn, et al.
Behring Institute Mitteilungen|May 1, 1984
The expression of tumor-associated antigens in primary and metastatic human malignant melanomaJ Brüggen, E B Bröcker, L Suter, et al.
Journal of the National Cancer Institute|March 1, 1995
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vesselsD Schadendorf, J Heidel, C Gawlik, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotypeE B Bröcker, G Zwadlo, L Suter, et al.
Pageof 17